Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-dose Neostigmine at TOF Ratio of 0.7 Accelerates Neuromuscular Recovery Without Adverse Effects: a Prospective Observational Study

NCT06745492 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT06745492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06745492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-dose Neostigmine at TOF Ratio of 0.7 Accelerates Neuromuscular Recovery Without Adverse Effects: a Prospective Observational Study
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Completed
Start date
October 1, 2022
Completion date
August 25, 2023
Enrollment
59 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recovery time